Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
30.22
-0.10 (-0.33%)
At close: Feb 11, 2026, 4:00 PM EST
29.77
-0.45 (-1.49%)
After-hours: Feb 11, 2026, 5:28 PM EST
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $2.7 billion as of February 11, 2026. Its market cap has increased by 70.57% in one year.
Market Cap
2.70B
Enterprise Value
2.75B
1-Year Change
70.57%
Ranking
Category
Stock Price
$30.22
Market Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $2.70B, an increase of 6,592.71%. That is a compound annual growth rate of 37.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 2.69B | -21.30% |
| Dec 31, 2025 | 3.42B | 151.45% |
| Dec 31, 2024 | 1.36B | 101.24% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apellis Pharmaceuticals | 2.89B |
| IDEAYA Biosciences | 2.86B |
| Tarsus Pharmaceuticals | 2.83B |
| Viridian Therapeutics | 2.82B |
| Dyne Therapeutics | 2.74B |
| Spyre Therapeutics | 2.73B |
| Immunome | 2.70B |
| Beam Therapeutics | 2.66B |